(Q38330522)

2 September 2017

title

A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome (English)

1 reference

2 September 2017

1 reference

Bethany D Freedman

1

1 reference

2 September 2017

Eun-Jig Lee

series ordinal

2

1 reference

2 September 2017

Youngkyu Park

series ordinal

3

1 reference

2 September 2017

J Larry Jameson

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

15 February 2005

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

280

1 reference

2 September 2017

issue

17

1 reference

2 September 2017

page(s)

17118-17125

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPARgamma, the ultimate thrifty gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Muscle-specific Pparg deletion causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

A dominant negative PPARgamma mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M407539200

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1074/JBC.M407539200

1 reference

2 September 2017

1 reference